Contact
Please use this form to send email to PR contact of this press release:
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
TO:
Please use this form to send email to PR contact of this press release:
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
TO: